Cat No:LP000097
Product Name:MGCD265;Glesatinib
CAS NO:875337-44-3
Purity: ≥99%
Solubility: In DMSO
Storage: -10°C
MGCD-265 is an orally bioavailable, multi-targeted tyrosine kinase inhibitor, inhibiting MET, VGFR1-3, Tie, and Ron. Formulations containing MGCD-265, alone or in combination with other chemotherapeutic compounds, are being tested in animal models and clinical cancer trials, particularly for non-small cell lung cancer.
